Radiotherapy of T1c prostate cancer.
With a 10-year local control rate of 85% to 100% and a low complication rate, radiotherapy is an effective treatment option for T1c prostate cancer. Controversial topics, such as treatment volumes and dose-response, are critically reviewed. New investigational approaches will be discussed.
Ben-Josef
E
E
Department of Radiation Oncology, Wayne State University, Detroit, MI, USA.
Porter
A T
AT
D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D018579:Patient Selection; D011471:Prostatic Neoplasms / Q000473:pathology / Q000532:radiotherapy*; D011878:Radiotherapy / Q000009:adverse effects / Q000379:methods; D011879:Radiotherapy Dosage; D015996:Survival Rate; D016896:Treatment Outcome